Please login to the form below

Not currently logged in
Email:
Password:

Portland Health appoints Jamie Hewitt as an account director

He was previously the National Rheumatoid Arthritis Society's government affairs head

Portand Health Jamie HewittLondon-based communications agency Portland Health has appointed Jamie Hewitt as an account director.

He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions.

Health partner Dr Jane Brearley said: “Jamie's skills will add a further dimension to Portland's health offer. His specific knowledge of healthcare charities and the challenges they face will further strengthen our ability to work productively with this important group of stakeholders. 

“This has been an exceptional year of growth for Portland Health, both in terms of team and client base and I am looking forward to an exciting 2016.”

Hewitt started his career working in a political consultancy before moving into public affairs roles for a non-departmental public body and two charities. 

During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to increase access to medicines, raise disease awareness and influence legislation on health, social care and welfare reform.

He said: “I'm very excited to be joining the Portland team, where I am being given the opportunity to work on some of the most high-profile and dynamic brands in healthcare. I'm particularly looking forward to the challenge of working for a top consultancy and helping Portland to grow its healthcare portfolio.”

10th December 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...

Infographics